• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees

Announcements


RAC Bisantrene IND UpdatePRICE SENSITIVE13:34 download Created with Sketch. 93.71KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE12/04/19 download Created with Sketch. 187.25KB
RAC Race files Bisantrene IND with FDAPRICE SENSITIVE25/03/19 download Created with Sketch. 96.57KB
RAC Appendix 3B13/03/19 download Created with Sketch. 107.21KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE27/02/19 download Created with Sketch. 1.15MB
RAC Principal Investigator appointed for BisantrenePRICE SENSITIVE25/02/19 download Created with Sketch. 117.33KB
RAC Appendix 3Y-Dr William Garner14/02/19 download Created with Sketch. 26.27KB
RAC Change in substantial holding12/02/19 download Created with Sketch. 54.69KB
RAC Change of Director's Interest Notice-Mr Chris Ntoumenopoulos12/02/19 download Created with Sketch. 26.19KB
RAC Change of Director's Interest Notice-Mr Peter Molloy12/02/19 download Created with Sketch. 24.46KB
RAC Change of Director's Interest Notice-Dr William Garner12/02/19 download Created with Sketch. 26.25KB
RAC Race Receives $228k R&D Tax Incentive RefundPRICE SENSITIVE31/01/19 download Created with Sketch. 88.33KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE25/01/19 download Created with Sketch. 97.6KB
RAC Race appoints leading haematologist to support BisantrenePRICE SENSITIVE22/01/19 download Created with Sketch. 116.72KB
RAC Appendix 3B22/01/19 download Created with Sketch. 150.65KB
RAC Change of Director's Interest Notice-Dr William Garner07/01/19 download Created with Sketch. 26.12KB
RAC Change of Director's Interest Notice-Dr William Garner31/12/18 download Created with Sketch. 26.18KB
RAC Change in substantial holding24/12/18 download Created with Sketch. 696.83KB
RAC Change in Director's Interest Notice-Peter Molloy24/12/18 download Created with Sketch. 24.49KB
RAC Change in substantial holding24/12/18 download Created with Sketch. 104.69KB
RAC Change of Director's Interest Notice-Dr William Garner24/12/18 download Created with Sketch. 27.42KB
RAC Cleansing Notice21/12/18 download Created with Sketch. 133.62KB
RAC Appendix 3B21/12/18 download Created with Sketch. 149.42KB
RAC Race signs agreement for Bisantrene NPP in IsraelPRICE SENSITIVE17/12/18 download Created with Sketch. 108.49KB
RAC Change in substantial holding13/12/18 download Created with Sketch. 48.19KB
RAC Change of Director's Interest Notice-Dr William Garner13/12/18 download Created with Sketch. 25.93KB
RAC Change of Director's Interests Notice-Dr John Cullity27/11/18 download Created with Sketch. 24.3KB
RAC Appendix 3B27/11/18 download Created with Sketch. 151.31KB
RAC Results of Annual General Meeting27/11/18 download Created with Sketch. 135.25KB
RAC Managing Director's AGM Presentation27/11/18 download Created with Sketch. 568.69KB
RAC Chairman's AGM Address27/11/18 download Created with Sketch. 85.98KB
RAC Change of Director's Interests Notice-Dr William Garner27/11/18 download Created with Sketch. 25.72KB
RAC Replacement-Change in substantial holding notice13/11/18 download Created with Sketch. 141.1KB
RAC Change in substantial holding12/11/18 download Created with Sketch. 97.84KB
RAC Change of Director's Interest Notice-Dr William Garner12/11/18 download Created with Sketch. 132.27KB
RAC Response to ASX Price QueryPRICE SENSITIVE01/11/18 download Created with Sketch. 652.83KB
RAC Race appoints Biosynergy to pursue Bisantrene licensingPRICE SENSITIVE01/11/18 download Created with Sketch. 101.31KB
RAC September 2018 Quarterly ReportPRICE SENSITIVE26/10/18 download Created with Sketch. 176.38KB
RAC Annual Report to Shareholders18/10/18 download Created with Sketch. 1.48MB
RAC Notice of Annual General Meeting/Proxy Form18/10/18 download Created with Sketch. 927.86KB
RAC Appendix 3B-Issue of Options01/10/18 download Created with Sketch. 156.46KB
RAC RAC appoints US consultant to drive partnering, investment01/10/18 download Created with Sketch. 96.83KB
RAC Expiry of Unlisted Options01/10/18 download Created with Sketch. 104.69KB
RAC Notification of 2018 Annual General Meeting Date28/09/18 download Created with Sketch. 87.52KB
RAC Details of Company Address28/09/18 download Created with Sketch. 84.53KB
RAC Change in substantial holding17/09/18 download Created with Sketch. 55.53KB
RAC Change of Director's Interest Notice-Dr William Garner17/09/18 download Created with Sketch. 132KB
RAC Race signs agreement with NSF Health Sciences to file IND17/09/18 download Created with Sketch. 92.57KB
RAC Investor Presentation-Broker Meets Biotech Conference13/09/18 download Created with Sketch. 1.22MB
RAC Appendix 3Y-Bill Garner30/08/18 download Created with Sketch. 25.26KB
RAC Appendix 3Y - Peter Molloy28/08/18 download Created with Sketch. 24.27KB
RAC Management and services changes at Race Oncology23/08/18 download Created with Sketch. 87.54KB
RAC Appendix 4G21/08/18 download Created with Sketch. 163.88KB
RAC Appendix 4E & Financial StatementsPRICE SENSITIVE21/08/18 download Created with Sketch. 2.52MB
RAC Investor Presentation03/08/18 download Created with Sketch. 1.15MB
RAC June 2018 Quarterly ReportPRICE SENSITIVE27/07/18 download Created with Sketch. 195.01KB
RAC FDA Grants Bisantrene Rare Paediatric Disease DesignationPRICE SENSITIVE18/07/18 download Created with Sketch. 135.44KB
RAC Trading HaltPRICE SENSITIVE16/07/18 download Created with Sketch. 523.3KB
RAC Appendix 3B-Issue of Options13/07/18 download Created with Sketch. 150.92KB
RAC Appendix 3B13/07/18 download Created with Sketch. 148.76KB
RAC Cleansing Notice02/07/18 download Created with Sketch. 133.35KB
RAC Appendix 3B02/07/18 download Created with Sketch. 151.1KB
RAC Expiry of Unlisted Options02/07/18 download Created with Sketch. 103.45KB
RAC Performance Share Milestones Met02/07/18 download Created with Sketch. 86.64KB
RAC Bisantrene poster presented at French Leukaemia ConferencePRICE SENSITIVE26/06/18 download Created with Sketch. 110.77KB
RAC Release of Securities from Escrow22/06/18 download Created with Sketch. 108.21KB
RAC Bisantrene approval in UK for supply as unlicensed medicinePRICE SENSITIVE21/06/18 download Created with Sketch. 89.63KB
RAC Results of General Meeting20/06/18 download Created with Sketch. 134.35KB
RAC Trading HaltPRICE SENSITIVE20/06/18 download Created with Sketch. 457.48KB
RAC Appendix 3Y - Peter Molloy18/06/18 download Created with Sketch. 24.24KB
RAC RAC cancer drug success in AML reported by French doctorsPRICE SENSITIVE05/06/18 download Created with Sketch. 110.54KB
RAC Expiry of Unlisted Options04/06/18 download Created with Sketch. 89.09KB
RAC Notice of General Meeting/Proxy Form17/05/18 download Created with Sketch. 705.71KB
RAC Race appoints Oncologist to head Medical Affairs15/05/18 download Created with Sketch. 112.45KB
RAC Race executes agreement for Bisantrene clinical trialPRICE SENSITIVE15/05/18 download Created with Sketch. 240.94KB
RAC Interview with Dr John Cullity07/05/18 download Created with Sketch. 106.38KB
RAC Investor Update30/04/18 download Created with Sketch. 122.68KB
RAC Appendix 3Y-Bill Garner27/04/18 download Created with Sketch. 25.33KB
RAC Appendix 4C - quarterlyPRICE SENSITIVE20/04/18 download Created with Sketch. 73.64KB
RAC Cleansing Notice13/04/18 download Created with Sketch. 132.1KB
RAC Appendix 3B13/04/18 download Created with Sketch. 149.58KB
RAC Race signs global distribution agreement with Durbin PLCPRICE SENSITIVE11/04/18 download Created with Sketch. 107.1KB
RAC Initial Director's Interest Notice06/04/18 download Created with Sketch. 63.6KB
RAC Final Director's Interest Notice04/04/18 download Created with Sketch. 165.28KB
RAC Race appoints former Sanofi executive to the Board04/04/18 download Created with Sketch. 108KB
RAC Change in substantial holding20/03/18 download Created with Sketch. 154.59KB
RAC Cleansing Notice19/03/18 download Created with Sketch. 97.06KB
RAC Appendix 3B-Placement19/03/18 download Created with Sketch. 149.75KB
RAC Race increases placement to $3.69mPRICE SENSITIVE16/03/18 download Created with Sketch. 85.57KB
RAC Race completes over-subscribed $3.159 million placementPRICE SENSITIVE12/03/18 download Created with Sketch. 107.47KB
RAC Trading HaltPRICE SENSITIVE07/03/18 download Created with Sketch. 185.36KB
RAC Section 708A Notice27/02/18 download Created with Sketch. 132.32KB
RAC Appendix 3B27/02/18 download Created with Sketch. 149.64KB
RAC Second Bisantrene Patent Allowed in USPRICE SENSITIVE21/02/18 download Created with Sketch. 106.1KB
RAC Appendix 4D & Half-Year Financial StatementsPRICE SENSITIVE20/02/18 download Created with Sketch. 782.89KB
RAC Section 708A Notice09/02/18 download Created with Sketch. 132.32KB
RAC Appendix 3B09/02/18 download Created with Sketch. 146.37KB
RAC Race Oncology Investor Presentation February 201809/02/18 download Created with Sketch. 2.9MB
RAC Appendix 4C - quarterlyPRICE SENSITIVE31/01/18 download Created with Sketch. 93.76KB
RAC Notice of Allowance for Bisantrene Patent in USPRICE SENSITIVE29/01/18 download Created with Sketch. 107.84KB
RAC Bisantrene IND Update
13:34PRICE SENSITIVE download Created with Sketch. 93.71KB
RAC Appendix 4C - quarterly
12/04/19PRICE SENSITIVE download Created with Sketch. 187.25KB
RAC Race files Bisantrene IND with FDA
25/03/19PRICE SENSITIVE download Created with Sketch. 96.57KB
RAC Appendix 3B
13/03/19 download Created with Sketch. 107.21KB
RAC Appendix 4D & Half-Year Financial Statements
27/02/19PRICE SENSITIVE download Created with Sketch. 1.15MB
RAC Principal Investigator appointed for Bisantrene
25/02/19PRICE SENSITIVE download Created with Sketch. 117.33KB
RAC Appendix 3Y-Dr William Garner
14/02/19 download Created with Sketch. 26.27KB
RAC Change in substantial holding
12/02/19 download Created with Sketch. 54.69KB
RAC Change of Director's Interest Notice-Mr Chris Ntoumenopoulos
12/02/19 download Created with Sketch. 26.19KB
RAC Change of Director's Interest Notice-Mr Peter Molloy
12/02/19 download Created with Sketch. 24.46KB
RAC Change of Director's Interest Notice-Dr William Garner
12/02/19 download Created with Sketch. 26.25KB
RAC Race Receives $228k R&D Tax Incentive Refund
31/01/19PRICE SENSITIVE download Created with Sketch. 88.33KB
RAC Appendix 4C - quarterly
25/01/19PRICE SENSITIVE download Created with Sketch. 97.6KB
RAC Race appoints leading haematologist to support Bisantrene
22/01/19PRICE SENSITIVE download Created with Sketch. 116.72KB
RAC Appendix 3B
22/01/19 download Created with Sketch. 150.65KB
RAC Change of Director's Interest Notice-Dr William Garner
07/01/19 download Created with Sketch. 26.12KB
RAC Change of Director's Interest Notice-Dr William Garner
31/12/18 download Created with Sketch. 26.18KB
RAC Change in substantial holding
24/12/18 download Created with Sketch. 696.83KB
RAC Change in Director's Interest Notice-Peter Molloy
24/12/18 download Created with Sketch. 24.49KB
RAC Change in substantial holding
24/12/18 download Created with Sketch. 104.69KB
RAC Change of Director's Interest Notice-Dr William Garner
24/12/18 download Created with Sketch. 27.42KB
RAC Cleansing Notice
21/12/18 download Created with Sketch. 133.62KB
RAC Appendix 3B
21/12/18 download Created with Sketch. 149.42KB
RAC Race signs agreement for Bisantrene NPP in Israel
17/12/18PRICE SENSITIVE download Created with Sketch. 108.49KB
RAC Change in substantial holding
13/12/18 download Created with Sketch. 48.19KB
RAC Change of Director's Interest Notice-Dr William Garner
13/12/18 download Created with Sketch. 25.93KB
RAC Change of Director's Interests Notice-Dr John Cullity
27/11/18 download Created with Sketch. 24.3KB
RAC Appendix 3B
27/11/18 download Created with Sketch. 151.31KB
RAC Results of Annual General Meeting
27/11/18 download Created with Sketch. 135.25KB
RAC Managing Director's AGM Presentation
27/11/18 download Created with Sketch. 568.69KB
RAC Chairman's AGM Address
27/11/18 download Created with Sketch. 85.98KB
RAC Change of Director's Interests Notice-Dr William Garner
27/11/18 download Created with Sketch. 25.72KB
RAC Replacement-Change in substantial holding notice
13/11/18 download Created with Sketch. 141.1KB
RAC Change in substantial holding
12/11/18 download Created with Sketch. 97.84KB
RAC Change of Director's Interest Notice-Dr William Garner
12/11/18 download Created with Sketch. 132.27KB
RAC Response to ASX Price Query
01/11/18PRICE SENSITIVE download Created with Sketch. 652.83KB
RAC Race appoints Biosynergy to pursue Bisantrene licensing
01/11/18PRICE SENSITIVE download Created with Sketch. 101.31KB
RAC September 2018 Quarterly Report
26/10/18PRICE SENSITIVE download Created with Sketch. 176.38KB
RAC Annual Report to Shareholders
18/10/18 download Created with Sketch. 1.48MB
RAC Notice of Annual General Meeting/Proxy Form
18/10/18 download Created with Sketch. 927.86KB
RAC Appendix 3B-Issue of Options
01/10/18 download Created with Sketch. 156.46KB
RAC RAC appoints US consultant to drive partnering, investment
01/10/18 download Created with Sketch. 96.83KB
RAC Expiry of Unlisted Options
01/10/18 download Created with Sketch. 104.69KB
RAC Notification of 2018 Annual General Meeting Date
28/09/18 download Created with Sketch. 87.52KB
RAC Details of Company Address
28/09/18 download Created with Sketch. 84.53KB
RAC Change in substantial holding
17/09/18 download Created with Sketch. 55.53KB
RAC Change of Director's Interest Notice-Dr William Garner
17/09/18 download Created with Sketch. 132KB
RAC Race signs agreement with NSF Health Sciences to file IND
17/09/18 download Created with Sketch. 92.57KB
RAC Investor Presentation-Broker Meets Biotech Conference
13/09/18 download Created with Sketch. 1.22MB
RAC Appendix 3Y-Bill Garner
30/08/18 download Created with Sketch. 25.26KB
RAC Appendix 3Y - Peter Molloy
28/08/18 download Created with Sketch. 24.27KB
RAC Management and services changes at Race Oncology
23/08/18 download Created with Sketch. 87.54KB
RAC Appendix 4G
21/08/18 download Created with Sketch. 163.88KB
RAC Appendix 4E & Financial Statements
21/08/18PRICE SENSITIVE download Created with Sketch. 2.52MB
RAC Investor Presentation
03/08/18 download Created with Sketch. 1.15MB
RAC June 2018 Quarterly Report
27/07/18PRICE SENSITIVE download Created with Sketch. 195.01KB
RAC FDA Grants Bisantrene Rare Paediatric Disease Designation
18/07/18PRICE SENSITIVE download Created with Sketch. 135.44KB
RAC Trading Halt
16/07/18PRICE SENSITIVE download Created with Sketch. 523.3KB
RAC Appendix 3B-Issue of Options
13/07/18 download Created with Sketch. 150.92KB
RAC Appendix 3B
13/07/18 download Created with Sketch. 148.76KB
RAC Cleansing Notice
02/07/18 download Created with Sketch. 133.35KB
RAC Appendix 3B
02/07/18 download Created with Sketch. 151.1KB
RAC Expiry of Unlisted Options
02/07/18 download Created with Sketch. 103.45KB
RAC Performance Share Milestones Met
02/07/18 download Created with Sketch. 86.64KB
RAC Bisantrene poster presented at French Leukaemia Conference
26/06/18PRICE SENSITIVE download Created with Sketch. 110.77KB
RAC Release of Securities from Escrow
22/06/18 download Created with Sketch. 108.21KB
RAC Bisantrene approval in UK for supply as unlicensed medicine
21/06/18PRICE SENSITIVE download Created with Sketch. 89.63KB
RAC Results of General Meeting
20/06/18 download Created with Sketch. 134.35KB
RAC Trading Halt
20/06/18PRICE SENSITIVE download Created with Sketch. 457.48KB
RAC Appendix 3Y - Peter Molloy
18/06/18 download Created with Sketch. 24.24KB
RAC RAC cancer drug success in AML reported by French doctors
05/06/18PRICE SENSITIVE download Created with Sketch. 110.54KB
RAC Expiry of Unlisted Options
04/06/18 download Created with Sketch. 89.09KB
RAC Notice of General Meeting/Proxy Form
17/05/18 download Created with Sketch. 705.71KB
RAC Race appoints Oncologist to head Medical Affairs
15/05/18 download Created with Sketch. 112.45KB
RAC Race executes agreement for Bisantrene clinical trial
15/05/18PRICE SENSITIVE download Created with Sketch. 240.94KB
RAC Interview with Dr John Cullity
07/05/18 download Created with Sketch. 106.38KB
RAC Investor Update
30/04/18 download Created with Sketch. 122.68KB
RAC Appendix 3Y-Bill Garner
27/04/18 download Created with Sketch. 25.33KB
RAC Appendix 4C - quarterly
20/04/18PRICE SENSITIVE download Created with Sketch. 73.64KB
RAC Cleansing Notice
13/04/18 download Created with Sketch. 132.1KB
RAC Appendix 3B
13/04/18 download Created with Sketch. 149.58KB
RAC Race signs global distribution agreement with Durbin PLC
11/04/18PRICE SENSITIVE download Created with Sketch. 107.1KB
RAC Initial Director's Interest Notice
06/04/18 download Created with Sketch. 63.6KB
RAC Final Director's Interest Notice
04/04/18 download Created with Sketch. 165.28KB
RAC Race appoints former Sanofi executive to the Board
04/04/18 download Created with Sketch. 108KB
RAC Change in substantial holding
20/03/18 download Created with Sketch. 154.59KB
RAC Cleansing Notice
19/03/18 download Created with Sketch. 97.06KB
RAC Appendix 3B-Placement
19/03/18 download Created with Sketch. 149.75KB
RAC Race increases placement to $3.69m
16/03/18PRICE SENSITIVE download Created with Sketch. 85.57KB
RAC Race completes over-subscribed $3.159 million placement
12/03/18PRICE SENSITIVE download Created with Sketch. 107.47KB
RAC Trading Halt
07/03/18PRICE SENSITIVE download Created with Sketch. 185.36KB
RAC Section 708A Notice
27/02/18 download Created with Sketch. 132.32KB
RAC Appendix 3B
27/02/18 download Created with Sketch. 149.64KB
RAC Second Bisantrene Patent Allowed in US
21/02/18PRICE SENSITIVE download Created with Sketch. 106.1KB
RAC Appendix 4D & Half-Year Financial Statements
20/02/18PRICE SENSITIVE download Created with Sketch. 782.89KB
RAC Section 708A Notice
09/02/18 download Created with Sketch. 132.32KB
RAC Appendix 3B
09/02/18 download Created with Sketch. 146.37KB
RAC Race Oncology Investor Presentation February 2018
09/02/18 download Created with Sketch. 2.9MB
RAC Appendix 4C - quarterly
31/01/18PRICE SENSITIVE download Created with Sketch. 93.76KB
RAC Notice of Allowance for Bisantrene Patent in US
29/01/18PRICE SENSITIVE download Created with Sketch. 107.84KB
(20min delay)
Last
7.4¢
Change
0.000(0.00%)
Mkt cap ! $6.455M
Open High Low Value Volume
7.4¢ 7.4¢ 7.4¢ $1.403K 18.95K

Buyers (Bids)

No. Vol. Price($)
1 34000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 54041 1
View Market Depth
Last update - 13.17pm 24/04/2019 (20 minute delay) ?
(live)
Last
7.2¢
  Change
0.000 ( 1.37 %)
Open High Low Volume
7.3¢ 7.3¢ 7.2¢ 20576
Last updated 14.13pm 24/04/2019 (live) ?
RAC (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.